Marion Silvia Schroeder
1 – 5 of 11
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register
(
- Contribution to journal › Article
- 2022
-
Mark
Exploration of real-world outcomes and treatment patterns in patients treated with anti-vascular endothelial growth factors for neovascular age-related macular degeneration in Sweden
(
- Contribution to journal › Article
-
Mark
What about the fellow eye in treatment of neovascular age-related macular degeneration? Analysis of data from the Swedish macula register
(
- Contribution to journal › Article
-
Mark
Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration
(
- Contribution to journal › Article
-
Mark
A novel phenotype associated with the R162W variant in the KCNJ13 gene
(
- Contribution to journal › Article